BBOT — Bridgebio Oncology Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSucker Stock

Annual balance sheet for Bridgebio Oncology Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	USG	USG	USG
Status:	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	0.25	156	425
Net Total Receivables	1.72	0.081	0.386
Prepaid Expenses
Total Current Assets	3.94	159	432
Net Property, Plant And Equipment	0.596	0.49	3.29
Other Long Term Assets
Total Assets	5.94	164	448
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	16.8	19.6	35
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	16.8	19.6	37.3
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-10.8	145	411
Total Liabilities & Shareholders' Equity	5.94	164	448
Total Common Shares Outstanding